APOE, MAPT, SNCA, and Cognitive Performance in Parkinson Disease

IMPORTANCE: Cognitive impairment (CI) is a common and disabling problem in Parkinson’s disease (PD) that is not well understood and is difficult to treat. Identification of genetic variants that influence the rate of cognitive decline or pattern of early cognitive deficits in PD might provide a clea...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:JAMA Neurol
Asıl Yazarlar: Mata, Ignacio F., Leverenz, James B., Weintraub, Daniel, Trojanowski, John Q., Hurtig, Howard I., Van Deerlin, Vivianna M., Ritz, Beate, Rausch, Rebecca, Rhodes, Shannon L, Factor, Stewart A., Wood-Siverio, Cathy, Quinn, Joseph F., Chung, Kathryn A., Peterson, Amie L., Espay, Alberto J., Revilla, Fredy J., Devoto, Johnna, Hu, Shu-Ching, Cholerton, Brenna A., Wan, Jia Y., Montine, Thomas J., Edwards, Karen L., Zabetian, Cyrus P.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2014
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4227942/
https://ncbi.nlm.nih.gov/pubmed/25178429
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2014.1455
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller